Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dr. Reddy’s Of India To Withdraw From Small Markets

This article was originally published in PharmAsia News

Executive Summary

India's Dr. Reddy's Laboratories plans to abandon small pharmaceutical markets around the world and concentrate on larger ones. According to Dr. Reddy's, the small markets account for less than one percent of the generics maker's revenues. A company spokesman said the withdrawal already is occurring in some countries across all regions of the world. Managing Director and COO Satish Reddy said the move is being made so the firm can be more assertive in key markets, redeploying its resources accordingly. The firm counts the United States, India, Russia, former Soviet republics and Germany as contributing 90 percent of its global revenues. (Click here for more
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC071129

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel